Texas 2009 - 81st Regular

Texas Senate Bill SB449

Filed
 
Out of Senate Committee
4/28/09  
Voted on by Senate
5/7/09  
Out of House Committee
5/20/09  
Voted on by House
5/27/09  
Governor Action
6/19/09  
Bill Becomes Law
 
Enrolled
5/28/09  

Caption

Relating to the penalty group classification of certain controlled substances.

Impact

The amendments proposed in SB449 could potentially alter the landscape of drug enforcement in Texas, particularly regarding substances that are deemed to have high abuse potential. By classifying specific drugs into different penalty groups, the bill could either increase or reduce the penalties associated with their possession or distribution. The revision fundamentally intends to align state laws with emerging patterns in drug usage and trafficking, potentially offering a more nuanced approach to the increasingly complex nature of substance abuse and addiction issues.

Summary

SB449 focuses on amending the penalty group classifications of certain controlled substances within the Texas Health and Safety Code. By making specific alterations to Section 481.102, the bill seeks to redefine the categorization of various opiates, hallucinogens, and stimulant substances among the existing penalty groups. This also includes changes to how certain opiate derivatives are treated under current drug laws. The revisions aim to provide a clearer framework for law enforcement in addressing controlled substances and their respective penalties.

Contention

Notable points of contention may arise during discussions regarding the specifics of which substances are included or excluded from each penalty group and how these classifications impact law enforcement's ability to control drug-related issues effectively. Critics might argue that the bill does not sufficiently address the public health implications of changing these classifications, particularly in the context of the opioid crisis. Supporters, however, may contend that these changes provide a more adequate response to the evolving drug landscape and enable law enforcement to better tackle the challenges of illegal drug use.

Companion Bills

No companion bills found.

Previously Filed As

TX SB645

Relating to the designation of fentanyl poisoning for purposes of the death certificate and to the criminal penalties for certain controlled substance offenses; increasing a criminal penalty.

TX HB6

Relating to the designation of fentanyl poisoning or fentanyl toxicity for purposes of the death certificate and to the criminal penalties for certain controlled substance offenses; increasing a criminal penalty.

TX HB218

Relating to the criminal and licensing consequences of certain offenses relating to the possession of marihuana, certain tetrahydrocannabinols, certain synthetic cannabinoids, and drug paraphernalia; imposing a fee.

TX SB967

Relating to the criminal and licensing consequences of certain offenses relating to the possession of marihuana, certain tetrahydrocannabinols, certain synthetic cannabinoids, and drug paraphernalia; imposing a fee.

TX HB3620

Relating to repealing certain offenses and removing certain regulations relating to marihuana, cannabis, cannabinoids, synthetic cannabinoids, and paraphernalia.

TX HB224

Relating to removing criminal penalties for the possession or distribution of certain drug paraphernalia under the Texas Controlled Substances Act.

TX HB369

Relating to the criminal penalty for possession of certain small amounts of controlled substances in Penalty Group 1 or 1-B.

TX HB3578

Relating to increasing the criminal penalties for delivery of a controlled substance in Penalty Group 1-B to a child.

TX HB2330

Relating to the criminal penalties for certain controlled substance offenses; increasing a criminal penalty.

TX HB939

Relating to the penalty for certain offenders for possession of a small amount of certain controlled substances.

Similar Bills

CA AB2589

Controlled substances: human chorionic gonadotropin.

CA AB2783

Controlled substances: hydrocodone combination products: schedules.

CA AB1152

Controlled substances: human chorionic gonadotropin.

CA SB1502

Controlled substances: xylazine.

CA AB527

Controlled substances.

MS HB1342

Controlled substances; bring forward sections for unlawful possession of.

MS SB2283

Uniform Controlled Substances Act; revise schedules.

MS HB232

Uniform Controlled Substances Act; revise schedules.